Bicentennial Bites: February
Celebrating 200 Years as Cincinnati's university
In celebration of the University of Cincinnati’s 200-year anniversary, we are proud to announce Bicentennial Bites.
February's Bicentennial Bites partner is Share: Cheesebar, a Pleasant Ridge cheese shop owned by UC alumna Emily Frank, A&S ’96. Share will be donating 20 percent of the proceeds of their six-piece combo (3
What is Bicentennial Bites, you ask?
In 2019, UC will partner with select Cincinnati restaurants, each on a monthly basis, to provide a special deal or commemorative item for all Boldly Bearcats. When you purchase the specialty item, a portion of the proceeds will come back to UC to support scholarships. Now that’s #boldlybearcat.
Want to participate? Use #bicentennialbites and #boldlybearcat on social media when you enjoy your Bicentennial Bites and be entered to win a prize.
Can't get enough Bicentennial?
Visit 200.uc.edu for a list of ways to get involved and celebrate the University of Cincinnati's 200-year anniversary.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.